Barbara Montaruli

766 total citations
32 papers, 444 citations indexed

About

Barbara Montaruli is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Barbara Montaruli has authored 32 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 19 papers in Hematology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Barbara Montaruli's work include Systemic Lupus Erythematosus Research (20 papers), Platelet Disorders and Treatments (13 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Barbara Montaruli is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Platelet Disorders and Treatments (13 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Barbara Montaruli collaborates with scholars based in Italy, Netherlands and United Kingdom. Barbara Montaruli's co-authors include Dario Roccatello, A Vaccarino, MT Bertero, R. Carignola, Savino Sciascia, M. Bazzan, Stefania Stella, Francesco Marongiu, Vittorio Pengo and Erica De Candia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Chemistry and Frontiers in Immunology.

In The Last Decade

Barbara Montaruli

30 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Montaruli Italy 13 313 256 69 57 56 32 444
Carlos Tolosa Spain 4 328 1.0× 182 0.7× 30 0.4× 40 0.7× 46 0.8× 15 416
Kengo Gohchi Japan 13 294 0.9× 212 0.8× 86 1.2× 84 1.5× 37 0.7× 29 473
Virginie Dufrost France 10 272 0.9× 210 0.8× 33 0.5× 39 0.7× 34 0.6× 21 402
Erika Chang Canada 8 270 0.9× 141 0.6× 43 0.6× 80 1.4× 33 0.6× 9 325
Laya Blokzijl Netherlands 7 377 1.2× 222 0.9× 89 1.3× 69 1.2× 53 0.9× 8 440
Miguel Ángel Plasín Spain 5 281 0.9× 152 0.6× 26 0.4× 95 1.7× 82 1.5× 7 394
Thomas Sailer Austria 10 163 0.5× 308 1.2× 34 0.5× 43 0.8× 61 1.1× 14 450
Daniel A. Kaczor United States 5 214 0.7× 218 0.9× 62 0.9× 54 0.9× 21 0.4× 6 360
Gonzalo Pombo Argentina 7 189 0.6× 169 0.7× 36 0.5× 22 0.4× 33 0.6× 10 302
Graciela S Cerrato Argentina 8 222 0.7× 172 0.7× 67 1.0× 51 0.9× 20 0.4× 11 303

Countries citing papers authored by Barbara Montaruli

Since Specialization
Citations

This map shows the geographic impact of Barbara Montaruli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Montaruli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Montaruli more than expected).

Fields of papers citing papers by Barbara Montaruli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Montaruli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Montaruli. The network helps show where Barbara Montaruli may publish in the future.

Co-authorship network of co-authors of Barbara Montaruli

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Montaruli. A scholar is included among the top collaborators of Barbara Montaruli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Montaruli. Barbara Montaruli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radin, Massimo, Barbara Montaruli, Isabella Russo, et al.. (2025). Anti‐Phosphatidylserine/Prothrombin Antibodies Identify a Distinct Form of ITP. eJHaem. 6(5). e70154–e70154.
2.
Sciascia, Savino, Barbara Montaruli, & María Infantino. (2024). Antiphospholipid antibody testing. Medicina Clínica. 163. S4–S9. 6 indexed citations
3.
4.
Sciascia, Savino, Massimo Radin, Mario Bazzan, et al.. (2021). Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. Frontiers in Immunology. 12. 687534–687534. 19 indexed citations
5.
Bazzan, Mario, Tullia Todros, Silvana Tedeschi, et al.. (2020). Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome. Thrombosis Research. 196. 167–174. 13 indexed citations
6.
Montaruli, Barbara, et al.. (2019). Influence of hemolysis, icterus and lipemia on coagulation tests as performed on Cobas t511 new analyzer. Blood Coagulation & Fibrinolysis. 31(1). 48–54. 6 indexed citations
7.
8.
Bazzan, M., A Vaccarino, Stefania Stella, et al.. (2015). Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study). Lupus. 25(5). 479–485. 41 indexed citations
9.
Montaruli, Barbara, Corrado Vitale, Silvia Berutti, et al.. (2015). Dabigatran overdose. Blood Coagulation & Fibrinolysis. 26(2). 225–229. 8 indexed citations
10.
Montaruli, Barbara, Giulio Mengozzi, Filippo Molinari, et al.. (2012). Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy. Lupus. 21(7). 799–801. 11 indexed citations
11.
Bazzan, M., A Vaccarino, Stefania Stella, et al.. (2012). Thrombotic recurrences and bleeding events in APS vascular patients: A review from the literature and a comparison with the APS Piedmont Cohort. Autoimmunity Reviews. 12(8). 826–831. 24 indexed citations
12.
Pengo, Vittorio, Gentian Denas, Elisa Bison, et al.. (2010). Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). Thrombosis Research. 126(2). 150–153. 26 indexed citations
13.
Bazzan, Mario, et al.. (2009). Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study. Internal and Emergency Medicine. 4(6). 491–495. 16 indexed citations
14.
Rollino, Cristiana, Carlo Massara, Luca Besso, et al.. (2009). Carotid Intima-Media Thickness and Anti-Phospholipid Antibodies in Patients with Systemic Lupus Erythematosus. European Journal of Inflammation. 7(1). 19–23. 6 indexed citations
15.
Pengo, Vittorio, Alessandra Biasiolo, Paolo Gresele, et al.. (2007). Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. Journal of Thrombosis and Haemostasis. 5(5). 925–930. 73 indexed citations
16.
Stratta, Piero, Caterina Canavese, Susanna Ferrero, et al.. (1999). Catastrophic Antiphospholipid Syndromes in Systemic Lupus Erythematosus. Renal Failure. 21(1). 49–61. 9 indexed citations
17.
Montaruli, Barbara, et al.. (1997). Use of Modified Functional Assays for Activated Protein C Resistance in Patients with Basally Prolonged aPTT. Thrombosis and Haemostasis. 78(3). 1042–1048. 4 indexed citations
18.
Schinco, Piercarla, Alessandra Borchiellini, G. Tamponi, et al.. (1997). Lupus anticoagulant and thrombosis: role of von Willebrand factor multimeric forms.. PubMed. 15(1). 5–10. 5 indexed citations
19.
Montaruli, Barbara, et al.. (1996). Arterial and venous thrombosis in two Italian families with the factor V Arg506→ Gln mutation. European Journal Of Haematology. 57(1). 96–100. 3 indexed citations
20.
Koopman, Maria M.W., Harry R. Büller, Jan W. ten Cate, et al.. (1996). Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis. British Journal of Haematology. 92(3). 740–743. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Tolosa Breakdown of academic impact, for papers by Kengo Gohchi Breakdown of academic impact, for papers by Virginie Dufrost Breakdown of academic impact, for papers by Erika Chang Breakdown of academic impact, for papers by Laya Blokzijl Breakdown of academic impact, for papers by Miguel Ángel Plasín Breakdown of academic impact, for papers by Thomas Sailer Breakdown of academic impact, for papers by Daniel A. Kaczor Breakdown of academic impact, for papers by Gonzalo Pombo Breakdown of academic impact, for papers by Graciela S Cerrato
Rankless by CCL
2026